Evidence map›Paper›PMID 31284517›Full record

ArticleBiomolecules2019

Guanidinylation of Chitooligosaccharides Involving Internal Cyclization of the Guanidino Group on the Reducing End and Effect of Guanidinylation on Protein Binding Ability.

Hironori Izawa, Mizuki Kinai, Shinsuke Ifuku, Minoru Morimoto, Hiroyuki Saimoto

Abstract read
In one paragraph

Article in Biomolecules, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hironori IzawaGraduate School of Engineering, Tottori University, 4-101 Koyama-Minami, Tottori 680-8550, Japan. h-izawa@tottori-u.ac.jp.ORCID 0000-0002-8715-8462
Mizuki KinaiGraduate School of Engineering, Tottori University, 4-101 Koyama-Minami, Tottori 680-8550, Japan.
Shinsuke IfukuGraduate School of Engineering, Tottori University, 4-101 Koyama-Minami, Tottori 680-8550, Japan.
Minoru MorimotoDivision of Instrumental Analysis, Research Center for Bioscience and Technology, Tottori University, Tottori 680-8550, Japan.
Hiroyuki SaimotoGraduate School of Engineering, Tottori University, 4-101 Koyama-Minami, Tottori 680-8550, Japan. saimoto@chem.tottori-u.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In order to synthesize a promising material for developing a novel peptide/protein delivery system, guanidinylation of chitooligosaccharides with 1-amidinopyrazole hydrochloride was investigated herein. The production of guanidinylated chitooligosaccharides was demonstrated by infrared spectroscopy (IR), nuclear magnetic resonance (NMR), and elemental analyses. Interestingly, we found that the reducing end in the guanidinylated chitooligosaccharides was converted to a cyclic guanidine structure (2-[(aminoiminomethyl)amino]-2-deoxy-d-glucose structure). This reaction was carefully proven by the guanidinylation of d-glucosamine. Although this is not the first report on the synthesis of the 2-[(aminoiminomethyl)amino]-2-deoxy-d-glucose, it has provided a rational synthetic route using the high reactivity of the reducing end. Furthermore, we found that the interaction between chitooligosaccharides and bovine serum albumin is weak when in a neutral pH environment; however, it is significantly improved by guanidinylation. The guanidinylated chitooligosaccharides are useful not only for the development of a novel drug delivery system but also as a chitinase/chitosanase inhibitor and an antibacterial agent.

Indexed as

AnimalsCattleChitinChitosanCyclizationGuanidineMolecular StructureOligosaccharidesOxidation-ReductionProtein BindingSerum Albumin, BovineChitinChitosanGuanidineoligochitosanOligosaccharidesSerum Albumin, Bovine1-amidinopyrazole hydrochloridebovine serum albuminchitooligosaccharidecyclic guanidineguanidinylationreducing end

Identifiers

PMID31284517
PMCPMC6681198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.